Neuronetics Stock Analysis

Neuronetics Stock Analysis Notes

About 53.0% of the company shares are owned by institutional investors. The book value of Neuronetics was at this time reported as 1.18. The company recorded a loss per share of 1.22. Neuronetics had not issued any dividends in recent years. Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania. Neuronetics operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 198 people. To find out more about Neuronetics contact Keith Sullivan at 610 640 4202 or learn more at https://neurostar.com.

Neuronetics Investment Alerts

Neuronetics Upcoming and Recent Events

Neuronetics Largest EPS Surprises

View All Earnings Estimates

Neuronetics Stock Institutional Investors

Note, although Neuronetics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Neuronetics Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 29.44 M.

Neuronetics Profitablity

The company has Profit Margin (PM) of (0.45) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.52) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.52.

Management Efficiency

Neuronetics has return on total asset (ROA) of (0.169) % which means that it has lost $0.169 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0013) %, meaning that it created substantial loss on money invested by shareholders. Neuronetics' management efficiency ratios could be used to measure how well Neuronetics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 26th of November 2024, Return On Tangible Assets is likely to drop to -0.28. In addition to that, Return On Capital Employed is likely to drop to -0.33. At this time, Neuronetics' Net Tangible Assets are very stable compared to the past year. As of the 26th of November 2024, Other Current Assets is likely to grow to about 7.6 M, while Non Current Assets Total are likely to drop about 13.4 M.

Technical Drivers

As of the 26th of November, Neuronetics secures the Risk Adjusted Performance of 0.0416, mean deviation of 5.14, and Downside Deviation of 8.66. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Neuronetics, as well as the relationship between them. Please verify Neuronetics jensen alpha and downside variance to decide if Neuronetics is priced some-what accurately, providing market reflects its recent price of 0.97 per share. Given that Neuronetics is a hitting penny stock territory we strongly suggest to closely look at its total risk alpha.

Neuronetics Price Movement Analysis

Neuronetics Insider Trading Activities

Neuronetics Outstanding Bonds

Neuronetics Predictive Daily Indicators

Neuronetics Forecast Models

Neuronetics' time-series forecasting models are one of many Neuronetics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Neuronetics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Neuronetics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Neuronetics shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Neuronetics. By using and applying Neuronetics Stock analysis, traders can create a robust methodology for identifying Neuronetics entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Neuronetics analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Neuronetics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Neuronetics stock analysis indicators help investors evaluate how Neuronetics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Neuronetics shares will generate the highest return on investment. By understating and applying Neuronetics stock analysis, traders can identify Neuronetics position entry and exit signals to maximize returns.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Neuronetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuronetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Neuronetics is measured differently than its book value, which is the value of Neuronetics that is recorded on the company's balance sheet. Investors also form their own opinion of Neuronetics' value that differs from its market value or its book value, called intrinsic value, which is Neuronetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuronetics' market value can be influenced by many factors that don't directly affect Neuronetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.